Pathophysiology of cholesterol gallstone disease

被引:0
|
作者
MendezSanchez, N
CardenasVazquez, R
PoncianoRodriguez, G
Uribe, M
机构
[1] INST NACL NUTR SALVADOR ZUBIRAN, DEPT GASTROENTEROL, LIVER UNIT, CLIN HIGADO, MEXICO CITY 14000, DF, MEXICO
[2] FDN CLIN MED SUR, MEXICO CITY, DF, MEXICO
[3] UNIV NACL AUTONOMA MEXICO, FAC CIENCIAS, DEPT BIOL, MEXICO CITY 04510, DF, MEXICO
[4] UNIV NACL AUTONOMA MEXICO, FAC MED, DEPT FARMACOL, MEXICO CITY 04510, DF, MEXICO
关键词
gallstone; cholesterol; bile acid; gallbladder;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of the present paper is to review the current knowledge about cholesterol gallstone disease. It is generally accepted that the formation of cholesterol gallstone requires three major pathogenic defects, namely, supersaturation, nucleation and crystal growth as well as disorder of gallbladder motility. The supersaturation is necessary but not sufficient to explain stone formation, It has been suggested that nucleation is the key factor for gallstone formation. However, those three factors are necessary for the formation of cholesterol gallstones, and the presence of just one or two factors does not lead to stones. We also touch briefly on the results from studies performed in Mexico in this area.
引用
收藏
页码:433 / 441
页数:9
相关论文
共 50 条
  • [1] PATHOPHYSIOLOGY OF GALLSTONE DISEASE - SECRETION OF BILIARY LIPIDS AND CHOLESTEROL GALLSTONES
    GEROLAMI, A
    MONTET, JC
    [J]. BIOLOGIE ET GASTRO-ENTEROLOGIE, 1973, 6 (01): : 63 - 71
  • [2] PATHOPHYSIOLOGY AND PATHOGENESIS OF CHOLESTEROL GALLSTONE FORMATION
    HAY, DW
    CAREY, MC
    [J]. SEMINARS IN LIVER DISEASE, 1990, 10 (03) : 159 - 170
  • [3] Cholesterol gallstone disease
    Portincasa, Piero
    Moschetta, Antonio
    Palasciano, Giuseppe
    [J]. LANCET, 2006, 368 (9531): : 230 - 239
  • [5] Investigation of cholesterol gallstone disease
    Forrest, Karen
    Welch, Christine
    Williams, Earl
    Smart, Howard
    Lombard, Martin
    [J]. LANCET, 2006, 368 (9540): : 989 - 990
  • [6] Cholesterol synthesis inhibitors in cholesterol gallstone disease
    Smit, JWA
    Vanerpecum, KJ
    VanbergeHenegouwen, GP
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 56 - 60
  • [7] HEPATIC CHOLESTEROL-METABOLISM IN CHOLESTEROL GALLSTONE DISEASE
    REIHNER, E
    ANGELIN, B
    BJORKHEM, I
    EINARSSON, K
    [J]. JOURNAL OF LIPID RESEARCH, 1991, 32 (03) : 469 - 475
  • [8] Pathophysiology, Complications, Diagnosis and Treatment of Gallstone Disease
    Nicholson, Gavin T.
    [J]. JOURNAL OF THE PANCREAS, 2022, 23 (09): : 88 - 89
  • [9] Resistance to Cholesterol Gallstone Disease: Hepatic Cholesterol Metabolism
    Zhang, Chenghao
    Dai, Wanlin
    Yang, Shaojie
    Wu, Shuodong
    Kong, Jing
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (04): : 912 - 923
  • [10] Thyroid Dysfunction and Cholesterol Gallstone Disease
    Kube, Irina
    Zwanziger, Denise
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2020, 128 (6-7) : 455 - 461